The constituent and manner null in order conservation the T lymphocyte from the pathogenetic material of the lymph node disease and acquired immuno-defficiency syndrome

摘要

The invention relates to a composition intended for therapeutic use for preventing or combating infection, mainly in vivo, of T lymphocytes by LAV viruses. This composition contains, as active principle, anti-T4 antibodies, free or coupled covalently to an antiviral agent.